Skip to search formSkip to main contentSkip to account menu

BM 06.022

Known as: BM 06022, BM-06.022, BM-06022 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

ActilyseReteplasealteplase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosis.
Thrombus formation in anesthetized, open-chest dogs was induced by electrical injury to the intimal surface of the left… 
1990
1990
Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coli.
Since currently available thrombolytics still show disadvantages, such as administration by infusion, occurrence of intracranial… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)